TTI-621 (SIRPαFc), an immune checkpoint inhibitor blocking the CD47 "do not eat" signal, induces objective responses in patients with advanced, relapsed/refractory diffuse large B-cell lymphoma (DLBCL) Meeting Abstract


Authors: Ansell, S. M.; Flinn, I. W.; Maris, M. B.; O'Connor, O. A.; Lesokhin, A.; Advani, A. S.; Minden, M. D.; Percival, M. B. M.; Johnson, L. D. S.; Catalano, T.; Irwin, M.; Petrova, P. S.; Uger, R. A.; Sievers, E. L.; Chen, R. W.
Abstract Title: TTI-621 (SIRPαFc), an immune checkpoint inhibitor blocking the CD47 "do not eat" signal, induces objective responses in patients with advanced, relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419703127
PROVIDER: wos
Notes: Meeting Abstract: 4116 -- Source: Wos
MSK Authors
  1. Alexander Meyer Lesokhin
    106 Lesokhin